ALDH3B1
Basic information
Region (hg38): 11:68008578-68029282
Previous symbols: [ "ALDH7" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ALDH3B1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 3 | |||||
missense | 8 | |||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 8 | 3 | 0 |
Variants in ALDH3B1
This is a list of pathogenic ClinVar variants found in the ALDH3B1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
11-68015322-C-T | not specified | Uncertain significance (Dec 14, 2021) | ||
11-68015347-C-T | not specified | Uncertain significance (Jul 14, 2021) | ||
11-68015436-G-A | not specified | Uncertain significance (Aug 17, 2021) | ||
11-68021602-C-T | not specified | Uncertain significance (May 02, 2024) | ||
11-68021627-C-T | not specified | Likely benign (Dec 12, 2023) | ||
11-68021641-C-T | not specified | Uncertain significance (Mar 29, 2023) | ||
11-68022627-G-C | not specified | Uncertain significance (Jan 27, 2022) | ||
11-68026072-C-T | not specified | Uncertain significance (May 23, 2023) | ||
11-68027828-C-T | not specified | Likely benign (Jun 02, 2023) | ||
11-68027856-C-T | not specified | Uncertain significance (Aug 12, 2021) | ||
11-68027876-G-A | not specified | Likely benign (Oct 25, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ALDH3B1 | protein_coding | protein_coding | ENST00000539229 | 12 | 20697 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000624 | 0.898 | 771 | 124790 | 184 | 125745 | 0.922 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.959 | 259 | 306 | 0.846 | 0.0000214 | 2954 |
Missense in Polyphen | 68 | 92.921 | 0.7318 | 999 | ||
Synonymous | -0.107 | 130 | 128 | 1.01 | 0.00000967 | 894 |
Loss of Function | 1.58 | 11 | 18.3 | 0.601 | 8.44e-7 | 201 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 2.00 | 1.90 |
Ashkenazi Jewish | 1.00 | 0.886 |
East Asian | 0.990 | 0.950 |
Finnish | 1.00 | 0.924 |
European (Non-Finnish) | 1.00 | 0.913 |
Middle Eastern | 0.990 | 0.950 |
South Asian | 1.00 | 0.945 |
Other | 1.00 | 0.919 |
dbNSFP
Source:
- Function
- FUNCTION: Oxidizes medium and long chain saturated and unsaturated aldehydes. Metabolizes also benzaldehyde. Low activity towards acetaldehyde and 3,4-dihydroxyphenylacetaldehyde. May not metabolize short chain aldehydes. May use both NADP(+) and NAD(+) as cofactors. May have a protective role against the cytotoxicity induced by lipid peroxidation. {ECO:0000269|PubMed:17382292, ECO:0000269|PubMed:23721920}.;
- Pathway
- Glycolysis / Gluconeogenesis - Homo sapiens (human);beta-Alanine metabolism - Homo sapiens (human);Phenylalanine metabolism - Homo sapiens (human);Histidine metabolism - Homo sapiens (human);Metabolism of xenobiotics by cytochrome P450 - Homo sapiens (human);Drug metabolism - cytochrome P450 - Homo sapiens (human);Chemical carcinogenesis - Homo sapiens (human);Tyrosine metabolism - Homo sapiens (human);Neutrophil degranulation;Metabolism of lipids;Innate Immune System;Immune System;Metabolism;Phenylalanine degradation;2,-deoxy-α-D-ribose 1-phosphate degradation;Tyrosine metabolism;Sphingolipid de novo biosynthesis;Sphingolipid metabolism;Histidine degradation;putrescine degradation III
(Consensus)
Recessive Scores
- pRec
- 0.110
Haploinsufficiency Scores
- pHI
- 0.278
- hipred
- N
- hipred_score
- 0.170
- ghis
Essentials
- essential_gene_CRISPR
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.964
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Aldh3b1
- Phenotype
- hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); immune system phenotype; skeleton phenotype;
Gene ontology
- Biological process
- alcohol metabolic process;ethanol catabolic process;lipid metabolic process;sphingolipid biosynthetic process;cellular response to oxidative stress;neutrophil degranulation;aldehyde catabolic process;oxidation-reduction process
- Cellular component
- cytoplasm;cytosol;plasma membrane;secretory granule membrane;vesicle;specific granule membrane;extracellular exosome
- Molecular function
- 3-chloroallyl aldehyde dehydrogenase activity;aldehyde dehydrogenase (NAD) activity;aldehyde dehydrogenase [NAD(P)+] activity;protein binding